After-Market: $112.39 +0.08 (0.07 %) 5:22 PM ET
ETF Quote Details
|NAV (month end)||107.99|
|Premium (+)/Discount (-) (month end)||+6.08|
Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.
This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:
See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs
ETF Expense Ratio
|Dividend (Yield)||$0.72 (0.64%)|
|Issuer||STATE STREET GLOBAL ADVISORS|
The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the US common stocks listed on the NYSE, AMEX, NASDAQ National Market and NASDAQ Small Cap exchanges. The Pharmaceuticals Index is a modified equal weight index.
The SPDR S&P Pharmaceuticals ETF seeks to replicate as closely as possible, before expenses, the total return performance of the S&P Pharmaceuticals Select Industry Index.